Please login to the form below
Covid-19
This page shows the latest Covid-19 news and features for those working in and with pharma, biotech and healthcare.
BioNTech reveals plans to spend about €1bn more on research and development this year
The plans come after BioNTech ended 2022 with a cash balance of 13.9bn plus receivables, largely attributed to its COVID-19 vaccine market lead with partner Pfizer. ... The company has already started clinical trials of four new infectious disease
Latest news
-
WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
The World Health Organization (WHO) has published a new report highlighting the impact of the COVID-19 pandemic on access to medicines for non-communicable diseases (NCDs). ... The new report, Access to NCD medicines: emergent issues during the COVID-19
-
MHRA to introduce new UK clinical trials framework
Marc Bailey, MHRA chief science and innovation officer, said: “Our world-first COVID-19 approvals showed how important it is to ensure that regulation is flexible and agile.
-
JCVI recommends spring COVID-19 booster for those at highest risk
The Joint Committee on Vaccination and Immunisation (JCVI) has advised the UK government that those at the highest risk of severe COVID-19 should be offered an extra booster vaccination this ... Scotland has yet to announce plans for its booster campaign.
-
WHO countries begin negotiations on global pandemic preparedness agreement
the mistakes of the COVID-19 pandemic response, including in sharing life-saving vaccines, provision of information and development of local capacities. ... WHO has had a strong focus on pandemic prevention, preparedness and response (PPR) since the
-
Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children
Pfizer and BioNTech have submitted an application to the US Food and Drug Administration (FDA) for the emergency use of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine ... Vaccine manufacturers have been focused on the development of variant
More from news
Approximately 771 fully matching, plus 218 partially matching documents found.
Latest Intelligence
-
Improving cardiovascular disease care and awareness
PME: How did the COVID-19 pandemic impact care for patients with cardiovascular disease? ... We all know that the number of excess deaths related to COVID-19 is far greater than that, but this is still a significant number of potentially avoidable deaths
-
The impact of pharma congresses on HCPs – virtual and in person
Virtual congresses: a blur in the past? When COVID-19 rendered international medical events unfeasible, congresses generated virtual experiences.
-
Next congress, please: making the most of virtual pharmaceutical congresses
We’ve all seen and likely had firsthand experience of the strain COVID-19 has placed upon our healthcare professionals (HCPs), providers and us as patients. ... But there are many other aspects of ‘being HCPs’ that go beyond front-line care where
-
The state of pharma customer experience
Instead, the industry faces an environment that is still adjusting after the shocks that COVID-19 brought. ... largest markets, despite Germany and France having largely ended their own COVID-19 restrictions by then.
-
Mental health post-COVID-19: what are the consequences and lessons learned for healthcare?
Beyond the COVID-19 era: positive effects on people living with mental health conditions. ... Lessons learned: managing the ongoing implications of COVID-19 and preparing for the next pandemic.
More from intelligence
Approximately 16 fully matching, plus 190 partially matching documents found.
Latest appointments
-
Hanover Health appoints James Mole as a director
During his time at NHS England, he also served as head of media over the course of the COVID-19 pandemic, supporting regular Downing Street press conferences and managing journalist enquiries. ... He also offered senior counsel to NHS leaders, including
-
Amanda Pritchard becomes NHS England’s first female chief executive
other staff have responded so magnificently to the COVID-19 pandemic,” said Pritchard. ... inevitably built up in the face of rising COVID-19 infections.
-
EFPIA appoints Hubertus von Baumbach as president
But COVID-19 has also underlined the critical importance of a strong and competitive research, development and medical innovation ecosystem to address major health challenges and drive economic growth.
-
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
In this role, he oversaw all media relations for the UK’s COVID-19 vaccination programme, providing strategic advice to Vaccines Minister Nadhim Zahawi and Health and Social Care Secretary Matt
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
Seb Tucknott CEO &Co-founder IBD Relief. Although these types of PSPs are still useful and have merit, with the current focus on technology and COVID-19 changing the healthcare landscape, ... Likewise, CLLSupport have moved their events online due to
-
Could femtech be the answer to the gender health gap?
While the COVID-19 pandemic has accelerated the adoption of digital practices across many areas of healthcare (it is estimated that digital adoption for both consumers and businesses moved forward by ... MobiHealthNews. Published August 12, 2021.
-
The dissemination and consumption of medical literature is evolving
QxMD, part of the WebMD Health Network discusses how they are going to evolve its publication solution, Read by QxMD in 2023. Traditionally, new scientific data would be presented at specialist congresses, subsequently published in a peer-reviewed
-
Action on Anti-microbial resistance: Will the UK rise to the challenge
The COVID-19 pandemic and lockdown measures are likely to have affected AMR data, making it difficult to assess progress. ... The UK Government’s new consultation for the 2024-2029 AMR National Action Plan offers a unique opportunity to discuss progress
-
Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence
During the COVID-19 pandemic, multiple sclerosis (MS) experts were receiving many questions regarding the safety and efficacy of COVID-19 vaccination in patients receiving treatment for MS. ... A further 28 MS experts from 19 countries also voted on the
More from PMHub
Approximately 91 fully matching, plus 276 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- The state of pharma customer experience
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
